Release Date: 02/07/10 09:56 Summary: Notice under 1012DAA(2)(f) of the Corporations Act Price Sensitive: No Download Document 86.34KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling